Page 60 - Pharma

Reckitt Benckiser demerges pharma biz to form Indivior

While Indivior will be positioned as a specialty pharmaceuticals company, Reckitt Benckiser will continue its focus on consumer health and hygiene products

US FDA successfully inspects Shusun's plant

The audit for Shusun's England plant was held on first week of November 2014

Pochiraju Industries to raise Rs 150 cr for expanding biopharma unit

The phase II expansion of biopharma unit is underway and the company is considering various options to fund this expansion

Bristol-Myers Squibb to set up biologics facility in Ireland

The facility, to be built with an estimated cost of $900 million, is expected to be operational in 2019

Merck forms global alliance with Pfizer for co- developing cancer drug

As per the agreement, Merck will receive an upfront payment of $ 850 million and is eligible to receive regulatory and commercial milestone payments up to $ 2 billion

Ranbaxy files lawsuit against US FDA's Valcyte and Nexium rulings

US FDA had withdrawn tentative approvals for Ranbaxy's ANDAs for generics of Nexium and Valcyte because of the compliance issues with Ranbaxy facilities

Dow sells Angus Chemical to Golden Gate Capital for $1.215 bn

The divestiture aligns to Dow's efforts to achieve its identified target of $ 4.5 billion to $ 6 billion in proceeds from shedding non-strategic assets and businesses by year-end 2015

The importance of unexpected outcomes: Neal Williams

Organisations that are able to achieve an effective cross-departmental dialogue will be best placed to identify opportunities to transfer technologies from one business area to another

Venus Remedies receives approval for meropenem in Switzerland

The company has secured more than 40 marketing authorisations for the antibiotic drug, the global annual generic sales of which stood at $1,879 million in 2012

Aurobindo emerges winner to buy US-based Natrol with $132 mn bid

Natrol, which manufactures nutritional supplements, provides Aurobindo with strong brand reputation and presence in a variety of attractive supplement markets

Sunil Healthcare to increase gelatine capsule production by 30%

The company will add three new manufacturing machines at its Alwar plant to raise the capacity from 7.7 billion capsules to 10 billion

Perrigo Company buys Belgian OTC firm Omega Pharma for $4.5 bn

The deal, which will lead to the creation of top five global OTC company, will combine Perrigo's supply chain and operational excellence with Omega's OTC branding and regulatory expertise

GVK Bio acquires Vanta Bioscience

The acquisition enables GVK Biosciences to offer GLP toxicology services for pharmaceuticals, agrochemicals, nutraceuticals, and cosmetics

Dr Reddy's receives US FDA approval for Valcyte generic

This follows a decision of US FDA to revoke Ranbaxy's six months exclusivity for generic version of Valcyte

US FDA revokes Ranbaxy's approvals for antiviral and heartburn drugs

The regulator has cited the compliance status of Ranbaxy production facilities as the reasons for its decision

Government plans separate drug controller for ayurvedic drugs

According to Dr Harsh Vardhan, Government will push for standardisation in ayurvedic drug production and promote 'Brand India' in the global traditional medicines market

MedImmune acquires Definiens to strengthen immuno-oncology capabilities

AstraZeneca's arm will acquire 100 percent of Definiens' shares for an initial consideration of $150 million and make additional predetermined milestone payments

Vertellus buys fine chemical maker Pentagon Chemicals

The acquisition significantly expands Vertellus' manufacturing presence in the agrochemical and pharmaceutical sectors, significantly boosting life science chemistries

Suven begins phase I trials for Alzheimer's drug

The Hyderabad-based company has completed all the pre-clinical, safety and toxicological studies for new chemical entity

Labcorp to acquire Covance for $5.6 bn

The deal to creating world's leading healthcare diagnostics company